Systematic review: The relationship between interstitial lung diseases and gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics

Volumn 34, Issue 11-12, 2011, Pages 1295-1305

  Hershcovici, T ^a   Jha, L K ^a   Johnson, T ^a   Gerson, L ^b   Stave, C ^b   Malo, J ^c   Knox, K S ^c   Quan, S ^d   Fass, R ^a  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; SUCRALFATE;

ANTIREFLUX OPERATION; CORRELATION ANALYSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGEAL DYSMOTILITY; FIBROSING ALVEOLITIS; GASTROESOPHAGEAL REFLUX; HUMAN; INTERSTITIAL LUNG DISEASE; MIXED CONNECTIVE TISSUE DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; STOMACH FUNDOPLICATION; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE;

GASTROESOPHAGEAL REFLUX; HUMANS; LUNG DISEASES, INTERSTITIAL; PREVALENCE; RISK FACTORS;

EID: 81355127329     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04870.x     Document Type: Review

References (35)

1. Castriotta RJ, Eldadah BA, Foster WM, et al. Workshop on idiopathic pulmonary fibrosis in older adults. Chest 2010; 138: 693-703.
2. Ing AJ,. Interstitial lung disease and gastroesophageal reflux. Am J Med 2001; 111 (Suppl. 8A): 41S-44S.
3. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
4. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999; 44 (Suppl. 2): S1-16.
5. Bandeira CD, Rubin AS, Cardoso PF, Moreira Jda S, Machado Mda M,. Prevalence of gastroesophageal reflux disease in patients with idiopathic pulmonary fibrosis. J Bras Pneumol 2009; 35: 1182-9.
6. Sweet MP, Patti MG, Leard LE, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg 2007; 133: 1078-84.
7. Salvioli B, Belmonte G, Stanghellini V, et al. Gastro-oesophageal reflux and interstitial lung disease. Dig Liver Dis 2006; 38: 879-84.
8. Patti MG, Tedesco P, Golden J, et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J Gastrointest Surg 2005; 9: 1053-6.
9. Tobin R, Porter A, Mageto Y, Sillery J, Pope C, Raghu G,. Gastroesophageal reflux (GER) in idiopathic pulmonary fibrosis (IPF) patients. Gastroenterology 1997; 112: A313-A313.
10. Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006; 27: 136-42.
11. Tobin RW, Pope CE 2nd, Pellegrini CA, Emond MJ, Sillery J, Raghu G,. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 1804-8.
12. Gribbin J, Hubbard R, Smith C,. Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med 2009; 103: 927-31.
13. Mays EE, Dubois JJ, Hamilton GB,. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976; 69: 512-5.
14. Bradford WZ, Brown KK, Noble PW, et al. Chronic use of anti-gastroesophageal reflux (GER) medications in patients with idiopathic pulmonary fibrosis (IPF). Chest 2004; 126: 772S-772S.
15. Raghu G, Yang ST, Spada C, Hayes J, Pellegrini CA,. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 2006; 129: 794-800.
16. Nadrous HF, Olson EJ, Ryu JH,. Fundoplication for gastroesophageal reflux disease associated interstitial lung disease. Chest 2003; 124: 193S-194S.
17. Linden PA, Gilbert RJ, Yeap BY, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 2006; 131: 438-46.
18. Denis P, Ducrotte P, Pasquis P, Lefrancois R,. Esophageal motility and pulmonary function in progressive systemic sclerosis. Respiration 1981; 42: 21-4.
19. Troshinsky MB, Kane GC, Varga J, et al. Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med 1994; 121: 6-10.
20. Marie I, Dominique S, Levesque H, et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001; 45: 346-54.
21. Marie I, Ducrotte P, Denis P, Hellot MF, Levesque H,. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24: 1593-601.
22. Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009; 179: 408-13.
23. Gilson M, Zerkak D, Wipff J, et al. Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases. Eur Respir J 2010; 35: 112-117.
24. Fagundes MN, Caleiro MTC, Navarro-Rodriguez T, et al. Esophageal involvement and interstitial lung disease in mixed connective tissue disease. Respir Med 2009; 103: 854-860.
25. Caleiro MTC, Lage LV, Navarro-Rodriguez T, Bresser A, da Costa PA, Yoshinari NH,. Radionuclide imaging for the assessment of esophageal motility disorders in mixed connective tissue disease patients: relation to pulmonary impairment. Dis Esophagus 2006; 19: 394-400.
26. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165: 277-304.
27. Lee JS, Collard HR, Raghu G, et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 2010; 123: 304-11.
28. Derk CT, Jimenez SA,. Systemic sclerosis: current views of its pathogenesis. Autoimmun Rev 2003; 2: 181-91.
29. McCarthy DS, Baragar FD, Dhingra S, et al. The lungs in systemic sclerosis (scleroderma): a review and new information. Semin Arthritis Rheum 1988; 17: 271-83.
30. Altman RD, Medsger TA Jr, Bloch DA, Michel BA,. Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 1991; 34: 403-13.
31. Bryan C, Knight C, Black CM, Silman AJ,. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999; 42: 2660-5.
32. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H,. Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971; 75: 369-76.
33. Yarze JC, Varga J, Stampfl D, Castell DO, Jimenez SA,. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol 1993; 88: 870-6.
34. Maddern GJ, Horowitz M, Jamieson GG, Chatterton BE, Collins PJ, Roberts-Thomson P,. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis. Gastroenterology 1984; 87: 922-6.
35. Pearson JE, Wilson RS,. Diffuse pulmonary fibrosis and hiatus hernia. Thorax 1971; 26: 300-5.